Idarubicin |
|
| 4-Desmethoxydaunorubicin; IMI-30; Idarubicin Hydrochloride; NSC-256439; 4 Demethoxydaunorubicin; 4 Desmethoxydaunorubicin; Hydrochloride, Idarubicin; IMI 30; IMI30; NSC 256439; NSC256439 | |
| An orally administered anthracycline antineoplastic. The compound has shown activity against breast cancer, lymphomas and leukemias, together with the potential for reduced cardiac toxicity. | |